A Clinical Study on Arthritis.
Phase 2
- Conditions
- Health Condition 1: null- Amavata (Rheumatoid arthritis)
- Registration Number
- CTRI/2017/08/009423
- Lead Sponsor
- Rishikul Campus Haridwar UA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
Patients having classical features of Amavata.
Age group of 18-60 years.
Patients fulfilling American College of Rheumatology (ACR) criteria, 1987.
Both sero -positive and sero- negative cases were included in present study.
Exclusion Criteria
Chronicity for more than 15 years.
Having severe crippling deformity.
Patients with other systemic diseases like Cardiac disease, Tuberculosis, Diabetes mellitus, Hypertension.
Any other serious medically and surgically ill patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of therapy subjectively and objectively, all <br/ ><br>the signs and symptoms were given scoring <br/ ><br>depending upon their severity. <br/ ><br>The result thus obtained from individual patient was categorized as: <br/ ><br>Excellent â?¥75% relief <br/ ><br>Marked Improvement â?¥50% up to 74% relief <br/ ><br>Mild improvement â?¥25% up to 49% relief <br/ ><br>No improvement â?¤24% relief <br/ ><br> <br/ ><br>Timepoint: 60 days
- Secondary Outcome Measures
Name Time Method Exacerbations in sign and symptomsTimepoint: 1 month